Preclinical Pharmacology of Bilastine, a New Selective Histamine H1 Receptor Antagonist: Receptor Selectivity and in Vitro Antihistaminic Activity

By Corcóstegui Reyes   Labeaga Luis   Innerárity Ana   Berisa Agustin   Orjales Aurelio  

Drugs in R&D, Vol. 6, Iss. 6, 2005-01 ,pp. : 371-384

Adis International

Access to resources Recommend Favorite

In vitro and in vivo pharmacological characterization of J-113397, a potent and selective non-peptidyl ORL1 receptor antagonist

By Ozaki S.   Kawamoto H.   Itoh Y.   Miyaji M.   Azuma T.   Ichikawa D.   Nambu H.   Iguchi T.   Iwasawa Y.   Ohta H.  

European Journal of Pharmacology, Vol. 402, Iss. 1, 2000-08 ,pp. : 45-53

Elsevier

Access to resources Recommend Favorite

Pharmacological properties of -mangostin, a novel histamine H 1 receptor antagonist

By Chairungsrilerd N.   Furukawa K.-I.   Ohta T.   Nozoe S.   Ohizumi Y.  

European Journal of Pharmacology, Vol. 314, Iss. 3, 1996-10 ,pp. : 351-356

Elsevier

Access to resources Recommend Favorite

A water-soluble, stable dipeptide NK 1 receptor-selective neurokinin receptor antagonist with potent in vivo pharmacological effects: S18523

By Bonnet J.   Kucharczyk N.   Robineau P.   Lonchampt M.   Dacquet C.   Regoli D.   Fauchere J.-L.   Canet E.  

European Journal of Pharmacology, Vol. 310, Iss. 1, 1996-08 ,pp. : 37-46

Elsevier

Access to resources Recommend Favorite

Pharmacological profile of T-0632, a novel potent and selective CCK A receptor antagonist, in vivo

By Taniguchi H.   Yazaki N.   Yomota E.   Shikano T.   Endo T.   Nagasaki M.  

European Journal of Pharmacology, Vol. 312, Iss. 2, 1996-09 ,pp. : 227-233

Elsevier

Access to resources Recommend Favorite